122 related articles for article (PubMed ID: 34369597)
1. Clonotypic architecture of a Gag-specific CD8+ T-cell response in chronic human HIV-2 infection.
Moysi E; Darko S; Gea-Mallorquí E; Petrovas C; Almeida JR; Wolinsky D; Peng Y; Jaye A; Stewart-Jones G; Douek DC; Koup RA; Dong T; Rowland-Jones S
Eur J Immunol; 2021 Oct; 51(10):2485-2500. PubMed ID: 34369597
[TBL] [Abstract][Full Text] [Related]
2. CD8
Murakoshi H; Zou C; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M
Retrovirology; 2018 Jul; 15(1):46. PubMed ID: 29970102
[TBL] [Abstract][Full Text] [Related]
3. Persistent survival of prevalent clonotypes within an immunodominant HIV gag-specific CD8+ T cell response.
van Bockel DJ; Price DA; Munier ML; Venturi V; Asher TE; Ladell K; Greenaway HY; Zaunders J; Douek DC; Cooper DA; Davenport MP; Kelleher AD
J Immunol; 2011 Jan; 186(1):359-71. PubMed ID: 21135165
[TBL] [Abstract][Full Text] [Related]
4. Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection.
Lopes AR; Jaye A; Dorrell L; Sabally S; Alabi A; Jones NA; Flower DR; De Groot A; Newton P; Lascar RM; Williams I; Whittle H; Bertoletti A; Borrow P; Maini MK
J Immunol; 2003 Jul; 171(1):307-16. PubMed ID: 12817012
[TBL] [Abstract][Full Text] [Related]
5. HLA-E-restricted, Gag-specific CD8
Yang H; Rei M; Brackenridge S; Brenna E; Sun H; Abdulhaqq S; Liu MKP; Ma W; Kurupati P; Xu X; Cerundolo V; Jenkins E; Davis SJ; Sacha JB; Früh K; Picker LJ; Borrow P; Gillespie GM; McMichael AJ
Sci Immunol; 2021 Mar; 6(57):. PubMed ID: 33766848
[TBL] [Abstract][Full Text] [Related]
6. HLA-E-restricted HIV-1-specific CD8+ T cell responses in natural infection.
Bansal A; Gehre MN; Qin K; Sterrett S; Ali A; Dang Y; Abraham S; Costanzo MC; Venegas LA; Tang J; Manjunath N; Brockman MA; Yang OO; Kan-Mitchell J; Goepfert PA
J Clin Invest; 2021 Aug; 131(16):. PubMed ID: 34228645
[TBL] [Abstract][Full Text] [Related]
7. DNA Vaccination by Electroporation Amplifies Broadly Cross-Restricted Public TCR Clonotypes Shared with HIV Controllers.
Mukhopadhyay M; Galperin M; Patgaonkar M; Vasan S; Ho DD; Nouël A; Claireaux M; Benati D; Lambotte O; Huang Y; Chakrabarti LA
J Immunol; 2017 Nov; 199(10):3437-3452. PubMed ID: 28993513
[TBL] [Abstract][Full Text] [Related]
8. The link between CD8⁺ T-cell antigen-sensitivity and HIV-suppressive capacity depends on HLA restriction, target epitope and viral isolate.
Lissina A; Fastenackels S; Inglesias MC; Ladell K; McLaren JE; Briceño O; Gostick E; Papagno L; Autran B; Sauce D; Price DA; Saez-Cirion A; Appay V
AIDS; 2014 Feb; 28(4):477-86. PubMed ID: 24384691
[TBL] [Abstract][Full Text] [Related]
9. Highly avid, oligoclonal, early-differentiated antigen-specific CD8+ T cells in chronic HIV-2 infection.
Leligdowicz A; Onyango C; Yindom LM; Peng Y; Cotten M; Jaye A; McMichael A; Whittle H; Dong T; Rowland-Jones S
Eur J Immunol; 2010 Jul; 40(7):1963-72. PubMed ID: 20411566
[TBL] [Abstract][Full Text] [Related]
10. Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers.
Ferre AL; Lemongello D; Hunt PW; Morris MM; Garcia JC; Pollard RB; Yee HF; Martin JN; Deeks SG; Shacklett BL
J Virol; 2010 Oct; 84(19):10354-65. PubMed ID: 20668079
[TBL] [Abstract][Full Text] [Related]
11. De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection.
Allen TM; Yu XG; Kalife ET; Reyor LL; Lichterfeld M; John M; Cheng M; Allgaier RL; Mui S; Frahm N; Alter G; Brown NV; Johnston MN; Rosenberg ES; Mallal SA; Brander C; Walker BD; Altfeld M
J Virol; 2005 Oct; 79(20):12952-60. PubMed ID: 16188997
[TBL] [Abstract][Full Text] [Related]
12. T cell receptor V beta repertoire of the antigen specific CD8 T lymphocyte subset of HIV infected children.
McCloskey TW; Haridas V; Pahwa R; Pahwa S
AIDS; 2002 Jul; 16(11):1459-65. PubMed ID: 12131183
[TBL] [Abstract][Full Text] [Related]
13. Functionally impaired HIV-specific CD8 T cells show high affinity TCR-ligand interactions.
Ueno T; Tomiyama H; Fujiwara M; Oka S; Takiguchi M
J Immunol; 2004 Nov; 173(9):5451-7. PubMed ID: 15494492
[TBL] [Abstract][Full Text] [Related]
14. Impact of Gag sequence variability on level, phenotype, and function of anti-HIV Gag-specific CD8(+) cytotoxic T lymphocytes in untreated chronically HIV-infected patients.
López M; Soriano V; Lozano S; Martinez P; Sempere J; González-Lahoz J; Benito J
AIDS Res Hum Retroviruses; 2006 Sep; 22(9):884-92. PubMed ID: 16989614
[TBL] [Abstract][Full Text] [Related]
15. Biased TCR repertoire in HIV-1-infected patients due to clonal expansion of HIV-1-reverse transcriptase-specific CTL clones.
Kolowos W; Schmitt M; Herrman M; Harrer E; Löw P; Kalden JR; Harrer T
J Immunol; 1999 Jun; 162(12):7525-33. PubMed ID: 10358208
[TBL] [Abstract][Full Text] [Related]
16. CD8+ TCR repertoire formation is guided primarily by the peptide component of the antigenic complex.
Koning D; Costa AI; Hoof I; Miles JJ; Nanlohy NM; Ladell K; Matthews KK; Venturi V; Schellens IM; Borghans JA; Kesmir C; Price DA; van Baarle D
J Immunol; 2013 Feb; 190(3):931-9. PubMed ID: 23267020
[TBL] [Abstract][Full Text] [Related]
17. Minor viral and host genetic polymorphisms can dramatically impact the biologic outcome of an epitope-specific CD8 T-cell response.
Geldmacher C; Metzler IS; Tovanabutra S; Asher TE; Gostick E; Ambrozak DR; Petrovas C; Schuetz A; Ngwenyama N; Kijak G; Maboko L; Hoelscher M; McCutchan F; Price DA; Douek DC; Koup RA
Blood; 2009 Aug; 114(8):1553-62. PubMed ID: 19542300
[TBL] [Abstract][Full Text] [Related]
18. HLA supertypes contribute in HIV type 1 cytotoxic T lymphocyte epitope clustering in Nef and Gag proteins.
Chakraborty S; Rahman T; Chakravorty R; Kuchta A; Rabby A; Sahiuzzaman M
AIDS Res Hum Retroviruses; 2013 Feb; 29(2):270-8. PubMed ID: 23061377
[TBL] [Abstract][Full Text] [Related]
19. TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection.
Chen H; Ndhlovu ZM; Liu D; Porter LC; Fang JW; Darko S; Brockman MA; Miura T; Brumme ZL; Schneidewind A; Piechocka-Trocha A; Cesa KT; Sela J; Cung TD; Toth I; Pereyra F; Yu XG; Douek DC; Kaufmann DE; Allen TM; Walker BD
Nat Immunol; 2012 Jun; 13(7):691-700. PubMed ID: 22683743
[TBL] [Abstract][Full Text] [Related]
20. Broad TCR usage in functional HIV-1-specific CD8+ T cell expansions driven by vaccination during highly active antiretroviral therapy.
Yang H; Dong T; Turnbull E; Ranasinghe S; Ondondo B; Goonetilleke N; Winstone N; di Gleria K; Bowness P; Conlon C; Borrow P; Hanke T; McMichael A; Dorrell L
J Immunol; 2007 Jul; 179(1):597-606. PubMed ID: 17579081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
